Oral Session 1-5A AML: AlloHSCT

[OS1-5A-5] Effect of allogeneic stem cell transplantation for patients with minimally differentiated AML

Satoshi Yamasaki¹, Jun Aoki², Jinichi Mori³, Kaito Harada⁴, Masashi Sawa⁵, Naoyuki Uchida⁶, Kazuteru Ohashi⁷, Takahiro Fukuda⁸, Shiro Koh⁹, Heiwa Kanamori¹⁰, Hiroyasu Ogawa¹¹, Hirokazu Okumura¹², Tatsuo Ichinohe¹³, Yoshinobu Kanda¹⁴, Junji Tanaka¹⁵, Yoshiko Atsuta¹⁶, Masamitsu Yanada¹⁷, Shingo Yano¹⁸ (1.Dpt.Hematol.,Kyushu Medical Center,Fukuoka,Japan, 2.Dpt.Hematol.,Yokohama City University Medical Center,Yokohama,Japan, 3.Dpt.Hematol.,Jyoban hospital,Iwaki,Japan, 4.Dpt.Hemato-Oncology,Tokai University School of Medicine,Isehara,Japan, 5.Dpt.Hemato-Oncology,Anjo Kosei Hospital,Anjo,Japan, 6.Dpt.Hematol.,Toranomon Hospital,Tokyo,Japan, 7.Hematology Division,Komagome Hospital,Tokyo,Japan, 8.Div.HSCT,National Cancer Center Hospital,Tokyo,Japan, 9.Dpt.Hematol.,Fuchu Hospital, Fuchu,Japan, 10.Dpt.Hematol.,Kanagawa Cancer Center,Yokohama,Japan, 11.Dpt.Hematol., Hyogo College of Medicine,Kobe,Japan, 12.Dpt of Internal Medicine,Toyama Prefectural Central Hospital,Toyoma,Japan, 13.Dpt.Hemato-Oncology,Hiroshima University,Hiroshima,Japan, 14.Div.Hematol.,Jichi Medical University Saitama Medical Center,Saitama,Japan, 15.Dpt.Hematol.,Tokyo Women's Medical University,Tokyo,Japan, 16.Dpt. Healthcare Administration,Nagoya Univ. Graduate School of Medicine,Nagoya,Japan, 17.Dpt.Hemato-Oncology,Fujita Health University School of Medicine,Toyoake,Japan, 18.Dpt.Hemato-Oncology,Jikei University School of Medicine,Tokyo,Japan)